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Abstract
Chronic wasting disease (CWD) is an emerging prion disease of free-ranging and captive cervids in North America. In this
study we established a rodent model for CWD in Syrian golden hamsters that resemble key features of the disease in cervids
including cachexia and infection of cardiac muscle. Following one to three serial passages of CWD from white-tailed deer
into transgenic mice expressing the hamster prion protein gene, CWD was subsequently passaged into Syrian golden
hamsters. In one passage line there were preclinical changes in locomotor activity and a loss of body mass prior to onset of
subtle neurological symptoms around 340 days. The clinical symptoms included a prominent wasting disease, similar to
cachexia, with a prolonged duration. Other features of CWD in hamsters that were similar to cervid CWD included the brain
distribution of the disease-specific isoform of the prion protein, PrP
Sc, prion infection of the central and peripheral
neuroendocrine system, and PrP
Sc deposition in cardiac muscle. There was also prominent PrP
Sc deposition in the nasal
mucosa on the edge of the olfactory sensory epithelium with the lumen of the nasal airway that could have implications for
CWD shedding into nasal secretions and disease transmission. Since the mechanism of wasting disease in prion diseases is
unknown this hamster CWD model could provide a means to investigate the physiological basis of cachexia, which we
propose is due to a prion-induced endocrinopathy. This prion disease phenotype has not been described in hamsters and
we designate it as the ‘wasting’ or WST strain of hamster CWD.
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Introduction
Chronic wasting disease (CWD) in deer and elk is an emerging
prion disease of wildlife in North America. The natural cervid
hosts for CWD include white-tailed deer (Odocoileus virginianus),
mule deer (Odocoileus hemionus hemionus), Rocky Mountain elk (Cervus
elaphus nelsoni), and moose (Alces alces shirasi) [1,2]. The disease is
characterized by a long incubation period of several years followed
by the insidious onset of a progressive and fatal neurodegenerative
disease [1]. Early symptoms in CWD can present as a wasting
syndrome, characterized by a loss of body mass, and behavioral
changes, both of which can span months in duration [1]. As CWD
progresses a wide variety of additional symptoms and neurological
disease have been observed and can include head tremors, ataxia,
excessive salivation due to difficulty in swallowing, and aspiration
pneumonia [1]. CWD is also a moderately contagious prion
disease in both captive cervid farms and among free-ranging deer
[3–5]. Prevalence rates of infection as high as 80% have been
reported in captive farms among does and yearling white-tailed
deer, and as high as 15% in free-ranging white-tailed bucks in the
core endemic area of CWD in southern Wisconsin, but the
prevalence is typically much lower [3–6]. Scrapie in certain breeds
of sheep is another prion disease that can be contagious among
sheep, but the other animal and human prion diseases are not
thought to be transmissible under natural conditions [7]. The
contagious nature of CWD and its more widespread geographic
distribution than previously recognized has raised concerns that
CWD, like bovine spongiform encephalopathy, may have zoonotic
potential either through direct consumption of venison or
indirectly by transmission to domestic animal species prior to
consumption by humans. To date, the epidemiological and
experimental data do not indicate that CWD is a zoonotic disease
[8–10]. This should not be mistaken for definitive evidence that
CWD is not zoonotic since the prevalence of CWD continues to
increase among free-ranging cervids, and the extent of human
exposure to CWD is difficult to estimate. The large number of
susceptible cervids, moderate infection rates, and lack of effective
strategies to control CWD transmission in wildlife has the potential
to give rise to new biological strains whose pathogenicity for
humans may be distinct from currently circulating CWD strains.
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28026As the percent of free ranging cervids with CWD increases, the
number of humans exposed to CWD will likely also increase
through consumption of venison from deer and elk with preclinical
CWD. In the U.S. and Canada, diagnosis and management of
CWD in wildlife should remain vigilant in order to minimize
human exposure since once the first human case related to CWD
were to become evident, it is likely that human exposure would be
widespread due to the long incubation period observed in prion
diseases.
CWD has been experimentally transmitted to non-cervid
species in order to investigate interspecies transmission to domestic
animals and non-human primates, and to establish CWD models
in new host species. An efficient method to transmit CWD to
rodents is to use PrP null mice lacking the endogenous murine
prion protein gene (Prnp) in order to generate a transgenic mouse
expressing Prnp from mule deer, white-tailed deer, or elk [9,11–
14]. These cervidized Prnp transgenic mice (TgMo-cerPrP) do not
exhibit a prolonged incubation period upon interspecies CWD
transmission compared to wild type mice, and have a similar
microscopic pattern and brain distribution of the disease-specific
prion protein, PrP
Sc, as found in the brain of cervids with CWD
[9,11]. TgMo-cerPrP are also a valuable tool used to bioassay for
CWD infectivity in tissues and fluids from CWD-infected cervids
[15]. However, studies in TgMo-cerPrP do not report other
disease characteristics that are specific to CWD in cervids
including preclinical behavioral alterations, weight loss and a
prolonged wasting disease, or PrP
Sc deposition in heart tissue.
Although CWD transmission has been successful to many other
host species including transgenic mice [9–11,16], hamsters
[16,17], bank voles [18], ferrets [17,19], mink [20], sheep [21],
cattle [22,23], and squirrel monkeys [24,25], and results in a fatal
neurodegenerative disease, many of the biological features distinct
to CWD in cervids are not recapitulated upon interspecies
transmission.
In the current study we investigated whether a model for CWD
can be established in Syrian golden hamsters (SGH) that maintains
key features of CWD in cervids. The rationale to pursue a SGH
model was partially based on the ability to transmit many of the
prion diseases (e.g., Creutzfeldt-Jakob disease, sheep scrapie,
bovine spongiform encephalopathy, transmissible mink encepha-
lopathy, and CWD) to SGH in order to investigate molecular and
cellular mechanisms of disease. These studies have elucidated key
aspects of prion pathogenesis including the physiochemical nature
of the prion agent [26], the molecular basis of prion strain diversity
[27–29], the physiological basis of prion-induced endocrine
changes [30–32], routes of prion neuroinvasion [33,34], the role
of the lymphoreticular system in prion neuroinvasion [35], and the
role of centrifugal prion spread in agent shedding [36], as well as
many other biological features of prion diseases. To shorten the
length of the incubation period previously reported upon
interspecies transmission of CWD into SGH, we used a previously
described approach in which CWD was inoculated into transgenic
mice lacking the endogenous murine Prnp and overexpressing
SGH Prnp using the rat neuron-specific enolase promoter (TgMo-
sghPrP) [37,38]. Serial passage of CWD into TgMo-sghPrP and
subsequently into SGH resulted in a fatal neurodegeneration that
was characterized by preclinical alterations in locomotor and
behavioral activity and a prolonged wasting disease. In CWD-
infected SGH the PrP
Sc distribution in brain had many similarities
to CWD in cervids and the peripheral tissue distribution of PrP
Sc
included the adrenal gland, pancreas, and heart, which are also
characteristic of natural CWD [39–41]. We also observed an
interesting prion distribution in the olfactory mucosa in which
PrP
Sc deposition is primarily found at the border of the sensory
epithelium and the lumen of the nasal airway, and we propose that
this has implications for CWD shedding into nasal secretions and
possibly for prion transmission. This study demonstrates that key
features of CWD in cervids can be maintained upon interspecies
passage and adaptation to the SGH and this model could be used
to investigate the physiological basis of prion-induced wasting
disease.
Results
Behavioral and clinical features of CWD in hamsters
To adapt CWD to rodents, we inoculated transgenic mice that
express the SGH prion protein gene (Prnp), (TgMo-sghPrP), with
two field isolates of CWD from clinical white-tailed deer.
Subsequently, we inoculated SGH with CWD passaged into
TgMo-sghPrP after one, two or three serial passages in order to
adapt CWD to hamsters. We hypothesized that CWD should
adapt faster upon interspecies and intraspecies passage in TgMo-
sghPrP (i.e., shorter incubation periods) than SGH since they
express approximately four-fold higher levels of SGH PrP
C than
wild type SGH in the brain [16,42]. With respect to Prnp genotype,
experimental prion transmission between TgMo-sghPrP and SGH
maintains the primary structure between the host PrP
C and
infectious PrP
Sc and therefore, is analogous to an intraspecies
transmission since this is the primary molecular determinant for
efficient transmission between hosts [43]. One goal of this study
was to establish CWD in SGH because this host species has been
used to successfully investigate several prion diseases including
scrapie [44], transmissible mink encephalopathy [27,45], bovine
spongiform encephalopathy [46,47], and Creutzfeldt-Jakob dis-
ease [48]. However, a prion disease characterized by a progressive
loss of body mass and cachexia has not been described in any of
the prion diseases adapted to SGH even though it is a prominent
feature of CWD in cervids. Table 1 summarizes a representative
portion of the CWD transmission data from one of the white-tailed
deer CWD isolates inoculated into TgMo-sghPrP and passaged
into SGH. At first passage of CWD into four TgMo-sghPrP
(recipient group M6148) the incubation period was 417623.6
days. In Passage Line A one mouse from this group, M6148.1
(Table 1, see ‘Inoculation Number’), with an incubation period of
369 days was serially passaged into TgMo-sghPrP by intracerebal
inoculation of a 1% (wt. vol.) brain homogenate and the
incubation periods were 19863.1 days at second serial passage
(Table 1 recipient group M6298-99), 18965.7 to 19863.5 days at
third serial passage (Table 1 recipient groups M6339 and M6337,
respectively), and 18761.8 days on the fourth serial passage
(Table 1 recipient group M6386). The length of the clinical phase
was very short in TgMo-sghPrP lasting approximately three days,
and was characterized by ptosis, kyphosis, wasting, and hyperac-
tivity. CWD passaged into TgMo-sghPrP from the first to third
serial passages were also inoculated into SGH. The incubation
periods upon first passage into SGH had a mean of between 355
and 389 days (Table 1 recipient groups H1429, H1470, H1471,
H1569), which in one case was similar to the incubation period in
one of the TgMo-sghPrP inocula (Table 1 inoculum number
M6148.1 at 369 days), but much longer than the incubation
periods in the other TgMo-sghPrP inoculum (Table 1 inoculum
numbers M6298.1, M6299.1 and M6339.2; incubation periods
ranging from 189 to 204 days). On second serial passage in SGH
the mean incubation periods were slightly reduced and ranged
from 322 to 343 days (Table 1 recipient groups H1570 and
H1572), which remained significantly longer than the ,200 day
incubation period found in TgMo-sghPrP. The initial neurological
symptoms in SGH infected with CWD were subtle and often it
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phase. Neurological symptoms of CWD in SGH included wasting,
hyperactivity, a mild hyperexcitability when handled, an elongated
horizontal posture during quadripetal motion, a mild impairment
of hind limb motor function, and a circling behavior in the late
stages of disease (Supplemental Video S1). Overall, serial passage
of CWD into TgMo-sghPrP resulted in an average incubation
period of between 187 to 198 days that when serially passaged into
SGH resulted in a longer average incubation period between 322
and 389 days even though both rodent species have a similar Prnp
genotype.
Although Passage Line A was representative of the majority of
our findings on experimental transmission of CWD into TgMo-
sghPrP, there were exceptions to this pattern. In Passage Line B,
another transgenic mouse brain from recipient group M6148,
M6148.3, which had an incubation period of 473 days, was
initially passaged at a 10
24 dilution into TgMo-sghPrP. This
resulted in an incubation period of 360616 days for recipient
group M6332 (Table 1). (This was different than Passage Line A in
which i.c. inoculation of brain homogenates were performed at a
10
22 dilution.) On third and fourth serial passages at a 10
22 brain
dilution, the incubation period shortened to 16064.6 and 15760
days, respectively (Table 1 recipient groups M6374 and M6388).
Inoculation of third passage transgenic mouse M6374.4 brain (an
incubation period of 151 days) into SGH resulted in an incubation
period of 477615.4 days even though overt neurological disease
was only observed in one of three hamsters (Table 1 recipient
group H1604). One hamster in this group was found dead at 456
days post-inoculation without any record of clinical symptoms,
although it is possible that subtle symptoms of disease were missed.
A second hamster was sacrificed at 468 days post-inoculation due
to symptoms more consistent with old age. Analysis for PrP
Sc
revealed high levels in the brain of both hamsters (data not shown).
A third hamster in this group was culled at 520 days post-
inoculation after a clinical course of several weeks. In this hamster
terminal symptoms were characterized by a circling behavior,
hyperactivity, and a loss of balance in the hind limbs when it
would rear into an upright position. This disease was similar to
hamster CWD from Passage Line A, but without the wasting
syndrome. The long incubation period for recipient group H1604
was unexpected since the transgenic mouse used as inoculum (i.e.,
M6374.4 had an incubation period of 151 days) had a shorter
incubation period than in TgMo-sghPrP used as CWD inoculum
in Passage Line A (e.g., M6339.2 had an incubation period 189
days) in which transmission to SGH had an incubation period of
35569.7 days (H1569.1) versus 477615.4 days for H1604
(Table 1). These findings suggest that multiple CWD phenotypes
can be isolated upon passage into TgMo-sghPrP, but additional
Table 1. Incubation period following serial passage of CWD isolate into transgenic mice and Syrian golden hamsters.
TgMo(sgh-PrP) Syrian golden hamster
Recipient Inoculum Number
2 Incubation Period, Incubation Period,
Group
1 (Incubation period) days ± SEM A/I
3 Pass No.
4 days ± SEM A/I Pass No.
M6148 CWD (na) 417623.6 4/4 First
Passage Line A:
M6298-99 M6148.1 (369 d) 19863.1 5/5 Second
H1429 M6148.1 (369 d) 38960 3/3 First
H1570 H1429.3 (389 d) 322610.2 4/4 Second
M6337 M6298.1 (204 d) 19863.5 5/5 Third
H1470 M6298.1 (204 d) 37363.1 4/4 First
M6339 M6299.1 (192 d) 18965.7 4/4 Third
H1471 M6299.1 (192 d) 37963.0 4/4 First
H1572 H1471.4 (382 d) 34365.0 8/8 Second
M6386 M6339.2 (189 d) 18761.8 4/4 Fourth
H1569 M6339.2 (189 d) 35569.7 4/4 First
Passage Line B:
M6332 M6148.3 (473 d) 360616 3/3 Second
M6374 M6332.1 (343 d) 16064.6 4/4 Third
M6388 M6374.4 (151 d) 15760 3/3 Fourth
H1604 M6374.4 (151 d) 477615.4
5 3/3 First
1Recipient rodents were either TgMo(sgh-PrP) indicated by a ‘M’ preceding the Recipient Group number or Syrian golden hamsters indicated by a ‘H’ preceding the
Recipient Group number.
2Inoculum was either a 10% brain homogenate (CWD isolate and M6148.1 inoculation of hamsters), a 1% brain homogenate (all other passages except one), or a 0.01%
brain homogenate (M6148.3) from an individual animal in the Recipient Group (indicated by .1, .2, .3, or .4). The incubation period of the transgenic mouse or Syrian
golden hamster used as inoculum is indicated in the parenthesis. Inoculation of M6148.1 into recipient group H1429 was by the intra-olfactory bulb route as previously
described.
3A/I, number affected with prion disease versus total number inoculated.
4Number of serial passages in either TgMo(sgh-PrP) or Syrian golden hamsters. Hamsters were inoculated with a CWD isolate that was serially passaged into TgMo(sgh-
PrP) for one, two, or three times.
5In recipient group H1604, one hamster was found dead at 456 days post-inoculation and a second exhibited characteristics of old age. They did not exhibit overt
symptoms of wasting disease or neurological dysfunction, but brain from these two SGH were positive for PrP
Sc. A third hamster was clinically positive for neurological
disease and PrP
Sc in brain.
doi:10.1371/journal.pone.0028026.t001
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CWD strains.
In SGH infected with CWD that was first passaged into TgMo-
sghPrP in Passage Line A, a progressive loss of body mass was
found beginning several weeks before onset of neurological
symptoms. An analysis of individual hamster body weight versus
time post-inoculation during the first 50 weeks post-inoculation
indicates that there was a statistically significant treatment6time
interaction (F(50,700)=2.84, p=0.0001; Figure 1A). Additional
analysis revealed a statistical difference between mock and CWD
hamster, but only at the 50-week time point (p,0.001, corrected
Bonferroni’s t-tests). Between 50 and 58 weeks post-inoculation
hamsters with CWD continued to lose body weight and were
culled when clinical symptoms progressed to the terminal stage of
disease, thus excluding additional paired statistical analysis after 50
weeks post-inoculation (Figure 1B). There was also a significant
treatment6time interaction in cage feed intake between mock and
CWD hamster groups (F(48,96)=3.64, p,0.0001; Figure 1C) and
a significant decrease in cage feed intake in CWD-infected SGH
from 48 to 50 weeks post-inoculation (Figure 1C; p,0.001,
corrected Bonferroni’s t-tests). This hypophagia was not due to an
inability to access food and water. The loss of body mass and
wasting disease was not initially accompanied by overt clinical
symptoms and changes in neurological behavior were subtle for
most of the clinical phase. At the time of sacrifice (mean of 54
weeks postinfection), the mean individual body weight for mock-
infected SGH was 19068.3 grams while for the CWD-infected
SGH it was 10263.2 grams, or a 45% reduction in average body
weight (p,0.0001; Figure 1D). This reduction in body weight did
not solely occur in the final few days before sacrifice, but was due
to a progressive loss of body mass for individual hamsters over a
mean duration of 7.2561.1 weeks (Figure 1A & 1B; data not
shown). This hypophagia and cachexia, or prolonged wasting
disease phenotype, has not previously been described in SGH with
prion disease and is designated as the ‘wasting’ or ‘WST’ strain of
hamster CWD.
The exploratory behavior of SGH infected with WST CWD
passaged into TgMo-sghPrP was evaluated in an open field
apparatus. This paradigm has been extensively used to evaluate
locomotor activity patterns, anxiety and thigmotaxis, which refers
to the tendency of rodents to remain close to the walls. Mock- and
CWD-infected SGH (Table 1 recipient group H1572) were tested
for three minutes every two to three weeks for a total of 19 weeks
(between 29 and 48 weeks postinfection). The mean speed and
distance traveled for the WST CWD-infected and control mock
animals are depicted in Figure 2A and 2B. The locomotor activity
of the two groups diverged at 43 weeks post-inoculation; CWD-
infected SGH exhibited .3-fold increase in speed and distance
compared to mock control SGH at that time point. Statistical
analysis revealed a significant group6session interaction for both
average speed (F(7,98)=5.662, p,0.05) and distance traveled
(F(7,98)=5.737, p,0.05). Post-hoc analysis revealed that the
average speed and distance traveled for CWD-infected animals
were significantly higher compared to mock SGH at both 43 and
48 weeks post-inoculation (p,0.001, corrected Bonferroni’s t-
tests). The onset of changes in locomotor activity in WST CWD-
infected hamsters occurred before statistically significant changes
in hamster body weight, cage feed intake, and overt neurological
symptoms of disease.
The behavior pattern of mock and WST CWD-infected SGH
was also evaluated with respect to rotation behavior (i.e. 360u
turn). Analysis of this locomotor activity revealed a significant
treatment6time interaction (F(7,98)=2.904, p,0.05) during the
19 weeks in which rotational activity was monitored and
subsequent analysis showed a significant difference at 43
(p,0.01, corrected Bonferroni’s t-tests) and 48 (p,0.001,
corrected Bonferroni’s t-tests) weeks post-inoculation (Figure 2C).
Evaluation of thigmotaxis behavior revealed that the amount of
time both groups spent in the outer zone of the apparatus (i.e.,
immediately adjacent to the wall) was significantly higher
compared to the amount of time in the center zone across all
testing sessions (Figure 2D, 2E, 2F). Animal behavior character-
ized by a propensity for areas close to walls (i.e., thigmotaxis) is a
normal pattern of rodent behavior. No differences were observed
between groups for the amount of time in the center, corner and
outer zones (Figure 2D, 2E, 2F; p.0.05). Separate analysis
revealed a significant treatment6time interaction for the number
of entries into each of the designated zones of the apparatus
(Figure 2G, 2H, 2I) and CWD-infected SGH entered all zones
(i.e., center, corner, outer) with a greater frequency than mock-
infected animals (p,0.05). These differences were only significant
at 48 weeks post-inoculation (p,0.01, corrected Bonferroni’s t-
tests). At 48 weeks post-inoculation, WST CWD-infected SGH
exhibited a 3.9-, 2.2- and 5.1-fold increase in the number of entries
into the center, corner, and outer zones, respectively. These data
indicate that the increase in locomotor activity observed in CWD-
infected SGH was not preferentially distributed to any particular
zone of the apparatus. The increase in the number of entries into
each of the zones at 48 weeks post-inoculation in CWD-infected
SGH may be partially due to the increase in locomotor activity
(e.g., distance traveled, average speed, number of rotations) and
hence, the number of times they travel through each zone.
Neuropathological changes in CWD infection of hamsters
To investigate whether neuropathological features of CWD in
hamsters had similarities to CWD in cervids, the brain distribution
of PrP
Sc in hamster WST CWD was evaluated by immunohisto-
chemistry. The PrP
Sc brain distribution pattern was similar in all
cases of hamster CWD for first and second passaged hamster
CWD, even though there was some degree of animal-to-animal
variation (Figure 3). The most consistent and intense PrP
Sc
deposition in hamster CWD was observed in nuclei of 1) the
forebrain particularly in the thalamus, hypothalamus, and to a
lesser degree the hippocampus (Figure 3C to 3F and 3K); 2) the
midbrain including the superior colliculus, substania nigra, and
mammillary nucleus (Figure 3C and 3D); and 3) several areas in
the caudal brainstem (Figure 3A, 3B, 3I, and 3J)(Table 2).
Microscopically, the PrP
Sc immunostaining in hamster CWD
brain varied from fine granular deposits to small aggregates to
plaque-like deposits, with all three patterns found throughout
affected brain regions (Figure 3I to 3K). PrP
Sc was primarily
located in the extracellular neuropil, but intracellular deposits were
sporadically observed particularly in the dorsal motor nucleus of
the vagus.
To assess the similarities of the brain PrP
Sc deposition pattern in
hamster CWD to cervid CWD, the global brain pattern of the
PrP
Sc distribution in hamster CWD was compared to the PrP
Sc
distribution in brain of cervids with CWD based on either prior
publications [39,49–52] or unpublished studies by one of us
(D.M.S.). This PrP
Sc analysis demonstrated that there were many
similarities between the two types of CWD in gray matter areas
including those in the forebrain, midbrain, and brainstem, but less
so in the cerebellum (Table 2). In contrast, there were small
differences in the degree of PrP
Sc deposition within several major
white matter tracts. In hamster CWD there was slightly less PrP
Sc
deposition in cortical white matter, the corpus callosum, and spinal
trigeminal tract, but slightly more severe in the cerebellar white
matter compared to that reported for cervid CWD (Table 2). In
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cerebellar peduncle, and internal capsule, the PrP
Sc intensity was
similar between hamster CWD and cervid CWD. At the cellular
level the morphological nature of the PrP
Sc deposits were
heterogenous and ranged from granular to plaque-like in CWD
infections of both hamsters and cervids. Overall, the morphology
and distribution of PrP
Sc in hamster WST CWD was largely
indistinguishable from terminal, CWD-infected cervids.
Distribution of peripheral infection in hamster CWD
To further investigate the biological relevance of CWD in
hamsters to CWD infection in the natural deer host, we analyzed
the distribution of PrP
Sc in the nervous, lymphoreticular,
endocrine, and olfactory systems as well as in skeletal muscle
and compared these results to those previously reported for the
PrP
Sc distribution in cervids with CWD [15,39–41,49–51,53–56].
Western blot revealed strong PrP
Sc deposition in the brain and
olfactory bulb, moderate-to-high levels in the nasal mucosa, and
lower levels in spleen and lymph nodes of SGH infected with
CWD on first and second passage from TgMo-sghPrP (Figure 4A
and 4B). This central and peripheral tissue distribution of PrP
Sc in
WST CWD-infected SGH is also found in many prion diseases,
while in the neuroendocrine system it has been mainly described in
natural prion diseases of deer and sheep and infection in heart
tissue has been described in deer and elk with CWD [39–
41,57,58]. In WST CWD-infected SGH PrP
Sc was found in both
the adrenal gland and pancreas with higher levels present in the
adrenal gland. The adrenal gland had higher levels of PrP
Sc than
both the spleen and submandibular lymph node in first passage in
SGH (Figure 4A). PrP
Sc deposition was also found in the heart and
tongue tissue with equivalent amounts on first passage, but higher
levels in the heart on second serial passage in SGH although
animal-to-animal variation was observed (Figure 4A and 4B).
PrP
Sc deposition was not detected in tissues from the nervous,
olfactory, peripheral endocrine, and musculature systems from
mock-infected SGH (Figure 4C). In WST CWD-infected SGH the
PrP
Sc deposition was consistent with the tissue distribution of PrP
Sc
in deer with CWD, specifically with respect to the adrenal gland,
pancreas, and heart tissue.
To further investigate the cellular distribution of PrP
Sc in the
heart, pancreas, and adrenal gland in hamsters with WST CWD,
PrP
Sc immunohistochemistry and dual immunofluorescence (IMF)
was performed and compared to the cellular PrP
Sc distribution in
these tissues in deer and elk with CWD as previously reported. To
determine the distribution of PrP
Sc in heart, dual IMF was
performed with PrP
Sc and desmin, a cytoskeletal protein in muscle
cells. Desmin immunofluorescence was localized to the Z band of
muscle cells in the heart and PrP
Sc deposits were found within
desmin-positive cells indicating prion infection of cardiac muscle
(Figure 5A to 5C). In the pancreas of hamsters with CWD, PrP
Sc
was almost exclusively observed in the Islets of Langerhans as
punctate deposits (Figure 6A and 6B). Dual IMF for PrP
Sc and
synaptophysin in the pancreas of hamster CWD revealed that
PrP
Sc deposition was limited to synaptophysin-positive structures,
which we interpret as prion infection localized to neuroendocrine
tissue in the Islets of Langerhans (Figure 6D to 6F). In the adrenal
gland, PrP
Sc punctate immunofluorescence was found in the
medulla of the adrenal gland and appeared restricted to PGP 9.5-
Figure 1. Time course of body weight and food intake in Syrian golden hamsters infected with chronic wasting disease. Mock
infected (#) and CWD infected hamsters (&) (see Table 1, recipient group H1572) were monitored weekly over the course of infection for individual
body weight (A, B), cage food intake (C), and individual body weight at sacrifice (D). Values in panels (A) and (C) are the mean 6 standard error of the
mean, while in panels (B) and (D) the body weight is for individual SGH with the mean indicated by the solid horizontal bar (D). For time course data
in (A) and (C), the curves for mock infected and CWD infected hamsters were compared by a mixed model ANOVA. In cases of a significant
interaction, post hoc comparisons at each weekly time point were conducted using t-tests (corrected Bonferroni’s t-test, * indicates p,0.001).
Hamsters (n=8 per treatment group) were sacrificed between 50 and 58 weeks post-inoculation (B). For illustration purposes (A, C), data points are
plotted for every other week.
doi:10.1371/journal.pone.0028026.g001
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Sc
was found within the neuroendocrine portion of the adrenal gland.
PrP
Sc deposits were not detected in the heart, pancreas, and
adrenal gland from mock-infected hamsters (Figures 5D, 6C, 6G,
and 6K). These findings demonstrate that PrP
Sc is localized to
cardiac muscle and peripheral neuroendocrine tissues in hamster
WST CWD and this is consistent with the PrP
Sc distribution in
these tissues from deer and elk with CWD as previously published
[39–41].
Distribution of hamster CWD in the olfactory system
Prion infection of the olfactory bulb and nasal mucosa
previously has been described in sheep with scrapie [57–59], deer
and elk with CWD [56], humans with sporadic Creutzfeldt-Jakob
disease [60,61], and hamsters with experimental prion disease
[35,62]. The olfactory mucosa has been proposed to be a site of
prion shedding since olfactory receptor neurons at this site can
replicate prions to high levels and prion infectivity is found in nasal
fluids [36,63]. In CWD infected SGH PrP
Sc was detected in
homogenates of the olfactory bulb and nasal mucosa at both the
first and second serial passages as described above (Figure 4A and
4B). The molecular weight of proteinase K digested PrP
Sc from the
nasal mucosa was characterized by a major PrP
Sc polypeptide at
approximately 27 kDa, this PrP
Sc polypeptide pattern was distinct
from that in the olfactory bulb and brain. This major PrP
Sc
polypeptide in the nasal mucosa extracts had a size that was
between the diglycosylated and monoglycosylated PrP
Sc polypep-
tides found in the central nervous system and other peripheral
tissues. Using immunohistochemistry PrP
Sc was found in the
olfactory bulb, but primarily in the glomerular layer and outer
plexiform layer on both first and second passage of WST CWD
into SGH (Table 3). In the nasal cavity, PrP
Sc was prominent in
the olfactory sensory epithelium (OSE), but not in nerve fibers in
the subepithelial layers or in the non-sensory epithelium on both
first and second serial passage in SGH (Figure 7A to 7D, Table 3).
Within the OSE the strongest PrP
Sc staining was observed along
the edge of the OSE at the interface with the lumen of the nasal
airway in a location consistent with the distal knob of the dendrites
Figure 2. Open field behavior in Syrian golden hamsters infected with chronic wasting disease. Mock infected (#) and WST CWD
infected hamsters (&) (see Table 1, recipient group H1572) were monitored over the course of infection for locomotor activities including average
speed (A), distance traveled (B), and total rotations (C) as well as thigmotaxis activities including time in the center (D), corner (E), and outer (F) zones,
and the number of entries into the center (G), corner (H), outer (I) zones. Exploratory behavior of individual hamsters was measured using an
automated tracking system (see Materials and Methods). Data for mock infected and CWD infected SGH were compared using a mixed model ANOVA
and in the case of statistical significant interactions, a paired comparison was conducted using corrected Bonferroni’s t-tests (* indicates p,0.001).
For each treatment group n=8 SGH.
doi:10.1371/journal.pone.0028026.g002
Cachexia in Hamsters with CWD
PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e28026projecting from olfactory receptor neurons (ORNs). Often this
PrP
Sc deposition pattern was continuous along the length of the
OSE border (Figure 7A to 7B, Table 3). A lower amount of PrP
Sc
was observed in the dendrite layer of ORNs, while moderate PrP
Sc
staining was observed in the cell layer of the OSE, which contains
the cell bodies of ORNs (Figure 7C and 7D, Table 3). Mock-
infected hamsters did not exhibit immunostaining for PrP
Sc in the
nasal mucosa (Figure 7E and 7F).
To further investigate the distribution of PrP
Sc in the OSE, laser
scanning confocal microscopy (LSCM) was used to examine the
spatial relationship of PrP
Sc to ORNs and the cilia of ORNs by
dual immunofluorescence for PrP
Sc and either olfactory marker
protein (OMP) or adenylyl cyclase III (ACIII), respectively. At low
magnification the PrP
Sc distribution was continuous with the outer
edge of the OMP-positive OSE layer while a lower level of PrP
Sc
immunofluorescence was observed in the cell body layer of the
OSE (Figure 8A to 8C), which was consistent with the PrP
Sc
immunohistochemistry (Figure 7C and 7D). A three-dimensional
reconstruction of the OSE at higher magnification revealed PrP
Sc
deposition within OMP-positive ORNs with evidence for
moderate amounts of PrP
Sc in cell bodies, lower amounts in the
dendrites of ORNs, and intense PrP
Sc labeling at the distal
dendrites of OMP-positive ORNs, which is adjacent to the lumen
of the nasal airway (Supplemental Video S2). This last PrP
Sc
deposition pattern could be associated with either dendritic knobs
of the ORNs, cilia of ORNs, or both structures. LSCM of PrP
Sc
and ACIII, which is located to the inner membrane of cilia that
project from the dendritic knobs of ORNs into the mucus layer,
revealed that the distribution of PrP
Sc at the edge of the airway
lumen was closely aligned with the ACIII distribution (Figure 8D
to 8F). A three-dimensional reconstruction of LSCM analysis of
PrP
Sc and ACIII revealed that the PrP
Sc pattern at the border
between the OSE and airway lumen was also consistent with a
distribution in the cilia of ORNs (Supplemental Video S3). Mock-
infected SGH did not exhibit evidence of PrP
Sc deposition
(Figure 8G to 8I). PrP
Sc deposition was not found in three-
dimensional reconstructions of the OSE from mock-infected SGH
when dual immunofluorescence was performed with OMP or
ACIII (Supplemental Video S4). This continuous PrP
Sc deposition
pattern along the edge of the OSE in WST CWD infected SGH
may have implications for prion agent shedding into nasal
secretions.
Discussion
A prominent feature of CWD in deer is a progressive loss of
body mass and adiposity over a period of weeks to months [1].
This observation is not unique among prion diseases since a
wasting phenotype is also found in sheep and goats with scrapie
[64]. Despite interspecies transmission of CWD and scrapie to
rodents, a similar progressive wasting disease has not been
described in SGH except in the terminal stages of disease [31].
In the current study, we describe a progressive loss of body mass
and cachexia over several weeks in SGH with CWD that resulted
in an average of .50% weight loss at the time of animal sacrifice
when hamsters were still active, but not yet moribund. We have
termed this progressive disease in SGH the ‘wasting’ phenotype or
WST strain of CWD since overt symptoms of neurological
symptoms were not prominent for most of the disease phase. The
loss of body mass in WST CWD in SGH was distinct from that
reported for other natural prion diseases adapted to SGH
including transmissible mink encephalopathy (e.g., HY and DY
strains) [27,28,31], scrapie (e.g., 263K, 22AH, Me7H strains)
[44,65], CWD [16,17], bovine spongiform encephalopathy
[46,66], and Creutzfeldt-Jakob disease [48] in which changes in
body mass were not evident until the late phases of clinical disease
or were not described. Changes in body weight have been
reported in sheep scrapie that was adapted to SGH, but in these
cases there is a preclinical obesity that is characterized by a .25%
increase in body mass for the 22CH and 139H scrapie agent
strains [30–32,67]. The cellular basis for either prion-induced
cachexia or obesity is not completely understood, but an analysis
Figure 3. Brain distribution of PrP
Sc in Syrian golden hamsters infected with chronic wasting disease. Brain sections from WST CWD
infected SGH (A through F and I through L) and mock-infected SGH (G, H) were stained with hematoxylin and eosin (A, C, E, G, L), or by PrP
Sc
immunohistochemistry (brown deposit) counterstained with hematoxylin (B, D, F, H, I, J, K). Key: CL, cerebellum; DCN, deep cerebellar nuclei; Pn,
pons; 7n, facial nerve; VC, ventral cochlear nucleus; py, pyramidal tract; Ctx, cerebral cortex; Am, amygdala; HC, hippocampus; SC, superior colliculus;
MG, medial geniculate nucleus; SNR, substantia nigra; M, mammillary nucleus; MC, motor cortex; Th, thalamic nuclei, Hy, hypothalamic nuclei; CPu,
caudate-putamen; icp, inferior cerebellar peduncle; ic, internal capusule; cc, corpus callosum; VPL, ventral posterolateral thalamic nucleus; and Rt,
reticular thalamic nucleus. Scale bars in I through K is 50 mm.
doi:10.1371/journal.pone.0028026.g003
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preclinical hyperphagia, non-fasted hyperinsulinemia with hyper-
glycemia, and fasted hyperleptinemia that is consistent with an
anabolic syndrome that had similarities to type II diabetes mellitus
[31,32]. A similar analysis was performed for HY TME in SGH
that exhibit a loss of body mass during the late clinical phase of
disease and these animals have a different profile that includes
hypersecretion of glucagon, increased fasted ß-ketones, fasted
hypoglycemia, and suppressed, non-fasted leptin [31]. It was
proposed that in HY TME the SGH had a catabolic syndrome
and we would predict that WST CWD in SGH would exhibit a
more severe catabolic syndrome than found in HY TME since the
weight loss was longer in duration and more pronounced.
Additional factors that may have also contributed to the severe
loss of body mass in WST CWD in SGH include the increased
locomotor activity (e.g., distance traveled, average speed, number
of rotations) that was first observed at 43 weeks postinfection and
hypophagia that was first recorded at 48 weeks postinfection.
Table 2. PrP
Sc distribution in the brain of hamsters infected
with CWD.
Brain region
PrP
Sc in
hamsters
PrP
Sc in
cervids
1
Forebrain:
Cortical gray matter +/++ +/++
Cortical white matter 0/++
Corpus callosum 0/++
Hippocampus +/++ +
Hypothalamic nuclei
2 ++/+++ ++/+++
Thalamic nuclei
3 ++/+++ +++
Amygdala ++ ++
Striatum ++ +
Internal capsule 0/++
Midbrain:
Superior colliculus +++ ++
Red nucleus ++ +
Substantia nigra +/++ ++
Oculomotor nucleus and tract ++ ++
Mammillary nucleus +++ ++
Cerebellum:
Molecular layer 0/++ /++
Granular cell layer 0/++ +
Purkinje cell layer 0/++ ++
Cerebellar white matter +/++ +
Inferior cerebellar peduncle 0/+ 0/+
Caudal Brainstem:
Dorsal motor nucleus of the vagus +++ +++
Raphe nuclei ++/+++ +/++
Reticular formation ++/+++ ++
Solitary nucleus ++ ++
Cochlear nucleus +++ ++
Vestibular nucleus +++ +/++
Paraolivary nucleus +++ +/++
Spinal trigeminal tract 0/++ +
Pyramidal tract 0/+ 0/+
Other:
Ependymal epithelium ++ ++
The relative intensity of PrP
Sc deposition in the hamster brain infected with
CWD was scored on a 0 to 3 scale with 0=no immunoreactivity, 1=mild
immunoreactivity, 2=moderate immunoreactivity, and 3=intense
immunoreactivity.
1PrP
Sc distribution data in cervids was extrapolated from previously published
reports and unpublished observations (D.M.S.) of terminal, CWD-infected
captive mule deer and experimentally, orally-inoculated mule deer and white-
tailed deer.
2Hypothalamic nuclei that were evaluated include the arcuate, dorsomedial,
supraoptic, paraventricular and subincertal nuclei.
3Thalamic nuclei that were evaluated include the centrolateral, laterodorsal,
lateral posterior, posterior, ventral posterolateral, posteromedial, ventromedial,
paracentral, paraventricular, and mediodorsal nuclei.
doi:10.1371/journal.pone.0028026.t002
Figure 4. Western blot for PrP
Sc in central and peripheral
tissues of Syrian golden hamsters infected with chronic
wasting disease. Tissues from hamsters infected with WST CWD after
first (A) and second (B) passage (see Table 1, recipient groups H1569
and H1572) and mock infected brain (C) were enriched for PrP
Sc by
differential ultracentrifugation and proteinase K digestion followed by
NuPAGE and anti-PrP western blot analysis. The amount of tissue
equivalents in milligrams (mg eq) loaded into each lane is indicated
below each tissue. Key: Br, brain; Ob, olfactory bulb; Nm, nasal mucosa;
Sm, submandibular lymph node; Sp, spleen; Ad, adrenal gland; Pn,
pancreas; To, tongue; and Ht, heart. Tick marks on the right vertical
frame of each panel indicate the 20 and 30 kDa molecular weight
markers.
doi:10.1371/journal.pone.0028026.g004
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postinfection. This data is suggestive of an increased energy
expenditure without an increase in energy intake for several weeks.
These prion-induced changes resulted in an imbalance between
caloric expenditure and intake and could have exacerbated the
loss of body mass.
The observed changes in open field behavior in WST CWD-
infected SGH, which proceeded the appearance of clinical signs,
are consistent with previous studies that reported increased
locomotor activity in rodent prion infections [68–70]. The present
study confirms and extends these findings by demonstrating
preclinical hyperactivity in the CWD SGH model. Increased
locomotor activity can represent a hyper-reactivity to novel stimuli
or impaired novelty-induced exploration. The detailed analysis of
open field behavior in the present study revealed no difference in
the thigmotaxis between control and infected SGH subjects, which
is indicative of normal emotionality [71]. In contrast, WST CWD
in SGH resulted in increased rotational behavior that has not been
previously reported. The direction (clockwise vs counterclockwise)
of increased rotational behavior observed in experimental
hamsters was not consistent and may represent differences in the
intra-hemispheric deposition of PrP
Sc in brain structures following
CWD infection. Although speculative, the wide spread distribution
of PrP
Sc in structures including the cerebellar white matter,
thalamus, hippocampus and substantia nigra can be link to the
observed changes in behavior. In addition, abnormal behavior and
motor deficits in prion disease models have been associated with
changes in the hypothalamo-pituitary-adrenal (HPA) axis [72].
Prion-induced changes in the HPA are also consistent with the
wasting syndrome observed in WST CWD in SGH and in cervids
with CWD. Irrespective of the origin or mechanism(s), early
behavioral markers of prion infection are of epidemiological
importance.
Prion-induced endocrinopathies have been proposed to be the
primary cause of either obesity or cachexia observed in natural and
experimental prion diseases [31,72]. These can be explained by
prion infection of the HPA that results in altered secretion of
neuroendocrine hormones or pituitary hormones [31,72]. These in
turnregulateendocrine gland function that can affectbody massand
adiposity. Alternatively, prions may directly infect peripheral
endocrine glands and alter hormone secretion. Support for these
mechanisms can be found in CWD in cervids, sheep scrapie, BSE in
Figure 5. Immunohistochemistry for PrP
Sc in heart in Syrian
golden hamsters infected with chronic wasting disease. Skeletal
muscle of heart from mock (D) and WST CWD-infected (A through C)
hamsters. Panels A through C are the same field of view that are
separated into three panels according to the immunofluorescence
staining. Heart was analyzed by dual immunofluorescence for desmin
(A, C, D) and PrP
Sc (B, C, D). ToProH-3 staining of nuclei is indicated by
blue fluorescence. Scale bar in A is 10 mm.
doi:10.1371/journal.pone.0028026.g005
Figure 6. Immunohistochemistry for PrP
Sc in neuroendocrine
tissues in Syrian golden hamsters infected with chronic
wasting disease. Pancreas (A through G) and adrenal gland (H
through K) from mock (C, G, K) and WST CWD-infected (A, B, D, E, F, H, I,
J) hamsters. Panels D through F, and H through J are the same field of
view, which are separated into three panels according to the
immunofluorescence staining. Pancreas was analyzed by dual immu-
nofluorescence for synaptophysin (D, F, G) and PrP
Sc (E, F, G) while the
adrenal gland was analyzed by dual immunofluorescence for PGP9.5 (H,
J, K) and PrP
Sc (I, J, K) using laser scanning confocal microscopy. Serial
sections of pancreas were also analyzed by hematoxylin and eosin (A)
and PrP
Sc immunohistochemistry (B, C; brown punctate aggregates)
and counterstained with hematoxylin. Scale bar in D and H is 10 mm
and in A the scale bar is 100 mm.
doi:10.1371/journal.pone.0028026.g006
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been found in hypothalamic nuclei, the pituitary gland, pancreas,
and/or adrenal gland [39,40,49,57,58,73–76]. In the current study
PrP
Sc deposition was also found in several hypothalamic nuclei, the
pancreas, and adrenal gland in WST CWD in SGH. In both the
adrenal gland and pancreas, PrP
Sc deposition was associated with
markers for neural structures within these tissues suggesting that
prion-induced changes in neural control of these endocrine glands
could alter hormone secretion. For example, localization of PrP
Sc to
PGP 9.5-positive structuresinthemedullaofthe adrenalgland could
result in a prion effect on sympathetic regulation of adrenaline and
noradrenaline, and previous studies have demonstrated increased
levels of catecholamines in blood of scrapie infected mice and
hamsters [77,78], and humans with fatal familial insomnia [79].
Similarly, in the pancreas of WST CWD in SGH, PrP
Sc deposition
was associated with synaptophysin-positive structures in the Islet of
Langerhans, which is the region containing the hormone producing
cells. In several prion diseases infection of the Islet of Langerhans is
reported as well as altered levels of pancreatic hormones in serum
including insulin and glucagons suggesting that these endocrinop-
athies are associated with prion infection of the endocrine system
[30–32]. In other studies, elevated serum levels of leptin, which acts
on the hypothalamus to suppress appetite, was described in 139H
scrapie in SGH despite evidence of hyperphagia and obesity [31].
These studies suggest that the dysregulation of the endocrine system
in prion diseases is complex and could be due to the targeting of
prion infection to multiple sites in both the central and peripheral
endocrine system.To understand the cellularbasis of wasting disease
in CWD additional studies are needed to investigate metabolite and
hormone serum levels involved in endocrine function and we
propose that the WST CWD in SGH can provide a model to
investigate the basis of prion-induced cachexia.
Transmission of CWD from white-tailed deer, mule deer, and
elk to TgMo-sghPrP and SGH was undertaken in a previous study
[16], and our transmission data of CWD from white-tailed deer
into the same founder line of TgMo-sghPrP and outbred SGH
produced some different findings. Raymond et al [16] demonstrate
a very long incubation period on interspecies transmission of
white-tailed deer CWD into TgMo-sghPrP (632673 days with 4
of 9 mice affected, but 8 of 9 mice were PrP
Sc-positive in brain)
that shortened to 272662 days on second serial passage, and
212632 and 237613 days on third serial passage. Our data
resulted in a 100% attack rate and a shorter incubation period on
interspecies passage (417623 days) that stabilized to 19863 days
on second serial passage, and did not significantly shorten on third
serial passage (18965 and 19863 days). Our transmission data on
CWD from TgMo-sghPrP into SGH was also distinct from the
previous study [16] in which the mean incubation periods ranged
from 408 to 462 days, while in the current study they consistently
resulted in mean incubation periods ranging from 322 to 379 days
on first and second serial passage into SGH. In passage line B we
did observe a longer incubation period (477615 days) that was
consistent with the studies by Raymond et al [16], but this
occurred after inoculation of brain material from a CWD infected
TgMo-sghPrP that had an incubation period that was 157 days
while in the earlier study the inocula was from CWD infected
TgMo-sghPrP that had incubation periods significantly longer
(.270 days). Therefore, the serial passage history of CWD in
TgMo-sghPrP was different between these two studies despite a
similar incubation period in a subset of SGH. A comparison of the
findings from these two studies may suggest that distinct strains of
CWD were isolated upon interspecies passage into TgMo-sghPrP
and serial passage into SGH, but these conclusions cannot be
reached based solely on incubation periods. More extensive
analysis of the biological and biochemical phenotypes of hamster
adapted CWD isolates would be necessary in order to identify
distinct strains of CWD in SGH. Despite intensive efforts to
identify CWD strains using TgMo-cervidPrP, which is a more
appropriate model for CWD strain identification, only two distinct
strains of CWD have been identified and these are strongly
influenced by a normal polymorphism in the cervid Prnp [80].
The WST CWD strain in SGH has several similarities to CWD
in cervids including a progressive wasting disease, a similar brain
distribution of PrP
Sc, and targeting of prion infection to the
neuroendocrine portion of the adrenal gland and pancreas.
Additionally, in natural prion diseases of humans and animals,
infection of cardiac muscle has only been described in elk and
white-tailed deer with CWD [41]. In WST CWD of SGH, PrP
Sc
was also prominent in heart by western blot and cardiac muscle by
immunofluoresence. These findings provide another parallel
between CWD infection of cervids and WST SGH. Prion
infectivity has been described in muscle from CWD deer [15]
Table 3. PrP
Sc distribution in nasal cavity and olfactory bulb.
Olfactory sensory epithelium Subepithelium
1 Olfactory bulb
2
Hamster Cell body Dendrite Knob Nerve bundle NALT ONL GL OPL M IPL
H1470.2 0.9
3 0.0 2.1 0.0 0.0 nd nd nd nd nd
H1470.3 0.0 0.0 0.9 0.1 0.0 0.0 0.9 0.3 0.0 0.0
H1471.2 0.6 0.0 1.6 0.0 0.0 0.0 0.8 0.5 0.0 0.0
H1471.3 0.3 0.0 1.2 0.0 0.0 0.0 1.1 0.5 0.0 0.0
H1472.1 1.4 0.2 2.9 0.5 0.0 0.0 3.0 2.2 0.0 0.0
H1472.3 0.5 0.0 1.5 0.0 0.0 0.0 0.7 0.8 0.4 0.0
Average: 0.6 ,0.1 1.7 ,0.1 0.0 0.0 1.3 0.8 ,0.1 0.0
SEM: 0.2 ,0.0 0.3 ,0.1 0.0 0.0 0.5 0.3 ,0.1 0.0
1Subepithelium of nasal mucosa; NALT, nasal-associated lymphoid tissue.
2Olfactory bulb structures include the ONL, outer nerve layer; GL, glomerular layer; OPL, outer plexiform layer, M, mitral layer; IPL, inner plexiform layer.
3The relative intensity of PrP
Sc deposition in the hamster brain infected with CWD was scored on a 0 to 3 scale with 0=no immunoreactivity, 1=mild immunoreactivity,
2=moderate immunoreactivity, and 3=intense immunoreactivity. For each hamster a minimum of twenty-four tissue sections were examined spanning the middle to
posterior portion of the nasal cavity.
nd, not done.
doi:10.1371/journal.pone.0028026.t003
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Sc can also be enriched from the tongue of deer and elk
infected with CWD [56]. Although low levels of PrP
Sc were also
described in heart of SGH infected with 263K scrapie and BSE
adapted to SGH [66,81], the levels described in WST CWD
appear to be moderately high since more PrP
Sc was present in
heart than in tongue. Previous studies demonstrate that PrP
Sc is
not detected in heart while the tongue has higher levels of prion
infectivity than other muscle types in 263K scrapie infected SGH
[82]. Prion protein deposition in cardiac tissue has also been
described in red deer that were experimentally infected with CWD
[83]. Other observations such as altered locomotor activity and the
distinct distribution of PrP
Sc in the olfactory sensory epithelium in
WST CWD of SGH have not been directly compared to cervids
with CWD in order to determine whether parallel findings are
maintained. An advantage of the WST CWD strain in SGH over
other rodent models of CWD could be its usefulness in
determining the mechanism of prion-induced wasting disease
since this key phenotype is maintained for CWD between the deer
host and the WST CWD hamster model.
Materials and Methods
Animal inoculations, preclinical measurements, and
tissue collection
Transgenic mice made from murine PrP null mice were
engineered to express the SGH prion protein controlled by the rat
neuron-enolase specific promoter as previously described (kind gift
of B. Chesebro and R. Race, NIH Rocky Mountain Laboratories,
Figure 7. Distribution of PrP
Sc in nasal cavity in Syrian golden hamsters infected with chronic wasting disease. Low (A, B) and high (C,
D, E, F) magnification photomicrographs of the nasal cavity from Syrian golden hamsters infected with WST CWD brain (A, B, C, D) and mock-infected
brain (E, F) were stained with hematoxylin and eosin (A, C, E,) or immunostained for PrP
Sc (brown deposit) and counterstained with hematoxylin (B, D,
F). Key: OSE, olfactory sensory epithelium; SE, subepithelial layer; ORN, olfactory receptor neurons; and DL, dendrite layer. Arrows indicate PrP
Sc
deposition at the border of the OSE layer and lumen of the nasal airway. Scale bar in D and F is 50 mm.
doi:10.1371/journal.pone.0028026.g007
Cachexia in Hamsters with CWD
PLoS ONE | www.plosone.org 11 December 2011 | Volume 6 | Issue 12 | e28026Hamilton, MT, USA) [37,38]. These mice will be abbreviated
throughout this study as TgMo-sghPrP or referred to as transgenic
mice since these were the only mice used in the current study.
These transgenic mice were estimated to have approximately a
four-fold higher level of PrP
C in the brain than found in SGH
[42]. TgMo-sghPrP were intracerebrally (i.c.) inoculated with
30 ml of a 10% weight per volume (w/v) brain (obex) homogenate
from two free range CWD-infected white-tailed deer from
Colorado. Brains from these CWD-infected transgenic mice were
serially passaged three additional times into additional TgMo-
sghPrP over a range of 10
22 to 10
24 brain dilutions. In addition,
brain homogenates from transgenic mice were serially passaged
into weanling, Syrian golden hamsters (Simonsen Laboratories,
Gilroy, CA) by i.c. inoculation with 50 ml of a 1% w/v brain
homogenate. Age-matched mock SGH (i.e., control group) were
also inoculated with brain homogenates from normal TgMo-
sghPrP or SGH. Following inoculation, individual hamster body
weight and cage food consumption were measured on a weekly
basis. TgMo-sghPrP and hamsters were observed at least three
times per week for the onset of clinical symptoms. Animals were
euthanized during the early stages of neurological disease. For
collection of tissues for immunohistochemical and immunofluo-
rescence analyses, hamsters were intracardially perfused with
periodate-lysine-paraformaldehyde (PLP) fixative, tissues dissected,
and processed for embedding in paraffin wax as previously
described [33,34]. For biochemical analysis unfixed tissues were
collected, immediately frozen on dry ice, and stored at 280uC
until use.
Figure 8. Distribution of PrP
Sc in olfactory sensory epithelium in Syrian golden hamsters infected with chronic wasting disease.
Laser scanning confocal microscopy of olfactory marker protein (OMP)(A, G), PrP
Sc (B, H), and for both OMP and PrP
Sc (Merge)(C, I) in Syrian golden
hamsters infected with TgMo-sghPrP CWD (A, B, C) and mock-infected hamsters (G, H, I). Laser scanning confocal microscopy of adenylyl cyclase III
(ACIII)(D), PrP
Sc (E), and for both ACIII and PrP
Sc (Merge)(F) in CWD infected SGH. Panels A through C, D through F and G through I are the same field of
view that are separated into three panels according to the immunofluorescence staining. ToProH-3 staining of nuclei is indicated by blue
fluorescence. Olfactory receptor neurons in the olfactory sensory epithelium (OSE width indicated by white line), and nerve fibers in the subepithelial
layer (SE), both express high levels of OMP (A, C and G and I). ACIII is located on the sensory cilia that project from the terminal dendrites of ORNs and
its distribution was prominent at the border between the OSE and airway lumen (D and F). The white arrow points to the distal edge of the OSE
where it borders the lumen of the nasal airway. Scale bar in A, D and G is 50 mm.
doi:10.1371/journal.pone.0028026.g008
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Each hamster was individually tested in a standard open field
apparatus initially every 14 days (three times) followed by every
three weeks for five additional times. The apparatus was a 77 cm
square with walls that were 65 cm in height. The floor was
covered with paper and then disposed of after each trial. Animals
were placed in the center of the apparatus and permitted to
explore the environment for three minutes during which activity
was recorded using an automated tracking system (ANY-maze,
Stoelting, IL, USA). A center, outer, and corner zones were
defined and the amount of time and entries into each zone were
determined as were the total distance traveled and the average
speed.
Tissue enrichment for PrP
Sc
Tissues were homogenized in lysis buffer (i.e., 10 mM Tris-HCl,
pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5% deoxycholate, and
0.5% ipegal detergent) to 10% (wt. vol.) using either 0.5 mm glass
beads (brain, olfactory bulb, adrenal gland), steel beads (spleen,
submandibular lymph node, heart, tongue), or zirconium oxide
beads (nasal turbinate) and a Bullet Blender (Next Advance,
Averill Park, NY)) at a setting of 6 for 3 minutes. Some tissues were
first dissociated using Liberase Blendzyme 2 (Roche Diagnostics,
Indianapolis, IN.) in digestion buffer (i.e., Hepes, pH 7.5, 10 mM
EDTA) at 55 mg/ml (for the submandibular lymph node and
tongue) and 200 mg/ml (for the pancreas) prior to mechanical
homogenization with the Bullet Blender. Enrichment for PrP
Sc
from these tissue lysates was performed following addition of N-
lauroylsarcosine, differential centrifugation in a Beckmann Opti-
ma
TM MAX ultracentrifuge (Beckman Coulter Instruments,
Fullerton, CA.), and limited proteinase K digestion as previously
described [35]. Proteinase K digestion was performed by
resuspending detergent insoluble pellets in TBS (one ml per mg
of original tissue weight) and incubating with proteinase K at
10 mg per ml for 30 minutes at 37uC as previously described [35].
PrP
Sc western blot and immunohistochemistry
Tissues enriched for PrP
Sc (1 to 50 mg of tissue equivalents per
lane) were analyzed on a 12% MOPS NuPAGE gel (Invitrogen,
Carlsbad, CA) and proteins were transferred to PVDF membrane.
Western blot was performed as previously described using
monoclonal anti-PrP 3F4 antibody (gift of V. Lawson, National
Institute of Allergy and Infectious Diseases, Rocky Mountain
Laboratories, Hamilton, MT), anti-mouse IgG alkaline phospha-
tase conjugate (Promega Corporation, Madison, WI), and western
blots were developed using CDP-Star substrate (Applied Biosys-
tems, Foster City, CA) and imaged with a Kodak Image Station
2000 MM (Eastman Kodak Company, Rochester, NY) [35]. The
molecular weight of immunoreactive polypeptides was estimated
using the 1D Kodak image software and the Magic Mark protein
ladder (Invitrogen Corporation, Carlsbad, CA) were used as
standards.
PrP
Sc immunohistochemistry (IHC) was performed as previ-
ously described [34,35]. Briefly, animals were intracardially
perfused with periodate-lysine-paraformaldehyde (PLP) fixative
followed by immersion fixation in PLP (five to seven hours for soft
tissues and 24–36 hours for skulls containing the nasal cavity and
olfactory bulb). Following immersion fixation, decalcification of
skulls was performed by immersion in 10% formic acid as
previously described [34,35]. Once bone was decalcified the nasal
cavity, and other tissues, were processed and embedded in paraffin
wax. Tissues from a minimum of three animals per group were
analyzed. All tissue sections were subjected to antigen retrieval by
treatment with formic acid (99% wt. vol.) for 10 minutes. Tissue
sections were successively incubated with anti-PrP monoclonal 3F4
antibody overnight at 4uC, then incubated with horse anti-mouse
biotinylated secondary antibody (1:400; Vector Laboratories,
Burlingame, CA) at room temperature for 30 minutes, followed
by streptavidin-horseradish peroxidase (HRP) at room tempera-
ture for 20 minutes. PrP
Sc was visualized by localization of HRP
activity with DAB+ (DAKO Cytomation, Carpinteria, CA). Tissue
sections were counterstained with hematoxylin and cover slip
mounted with Mounting Medium (Richard-Allen Scientific,
Kalamazoo, MI) for viewing with a Nikon Eclipse E600
microscope. Controls for PrP
Sc IHC included the use of mock-
infected tissues and substituting a similar concentration of murine
IgG isotype control for the anti-PrP 3F4 monoclonal antibody. A
minimum of 10 to 30 sections throughout the thickness of the
tissue was examined for each animal.
PrP
Sc dual immunofluorescence and laser scanning
confocal microscopy (LSCM)
For localization of prion infection to specific cell types or
structures, dual immunofluorescence was performed for PrP
Sc
staining and 1) olfactory marker protein (OMP; goat polyclonal
antibody at 1:750)(Wako Chemicals, Richmond, VA) or adenylyl
cyclase III (ACIII; rabbit polyclonal antibody at 1:1,600)(Santa
Cruz Biotechnology, Santa Cruz, CA.) in nasal mucosa, 2) desmin
(rabbit polyclonal at 1:50)(DAKO Cytomation, Carpinteria, CA)
in heart, 3) synaptophysin (rabbit monoclonal antibody at
1:1,600)(Epitomics, Burlingame, CA) in pancreas, and 4) PGP
9.5 (rabbit polyclonal antibody at 1:2,000)(Biogenesis, Kingston,
NH) in adrenal gland. Secondary detection of anti-PrP 3F4
antibody was performed by incubation with horse anti-mouse IgG
conjugated to biotin followed by a Alexa Fluor 488 streptavidin
conjugate (Invitrogen Corporation, Carlsbad, CA) at a 1:400
dilution for detecton of PrP
Sc, and either donkey anti-goat
antibody conjugated to Alexa Fluor 594 antibody (1:800;
Invitrogen Corporation, Carlsbad, CA) or goat anti-rabbit
antibody conjugated to Alexa Fluor 568 antibody (1:800;
Invitrogen Corporation, Carlsbad, CA) for detection of antibodies
to host structures as previously published [36,62]. The nuclear
counterstain ToProH-3 (Invitrogen Corporation, Carlsbad, CA)
was applied to some tissue sections at a 1:2,000 dilution for
10 min. Tissues from a minimum of three CWD-infected hamsters
and three mock-infected animals were examined for each staining
procedure.
LSCM images were visualized using a Zeiss LSM 510 Meta
confocal system equipped with a Zeiss Plan-Apochromat663/NA
1.40 and 6100/NA 1.2 oil objectives. Double immunofluores-
cence was imaged after excitation of Alexa Fluor 488 with an
Argon laser at a wavelength of 488 nm, and excitation of Alexa
Fluor 594 with a Helium/Neon laser at a wavelength of 543 nm as
previously described [36,62]. Images were scanned sequentially to
minimize crosstalk between channel and the pinhole aperture was
adjusted to 1.0 airy units or less for both channels while controlling
for identical pinhole diameters and subsequent optical slice
thickness. Individual images for stacks were at 0.1 micron per
optical slice. Three-dimensional movies were reconstructed from
image stacks using the Projection feature of the Zeiss AIM software
(Carl Zeiss Microimaging, LLC, North America).
Statistical Analysis
Behavioral data were evaluated separately using a mixed model
ANOVA. In the case of statistically significant interactions,
multiple post hoc comparisons were performed using corrected
t-tests (Bonferroni’s method).
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